glp-1 patch fda approved Patches: What They Are and What You Should Know FDA approves first generic GLP-1

The significant year-over-year (YoY) jump in GLP-1 coverage among the largest companies signals a key shift: the employer debate is moving from whether to cover weight loss drugs to how to do so sustainably.

The FDA has issued warning letters to 30 telehealth companies for reportedly making false claims about GLP-1 products

Clinical studies have provided strong evidence about GLP-1 safety

Most cases are centered in the southeastern part of Michigan, although illnesses have also been reported in Ohio, North Carolina, Illinois and New Jersey.

The purpose of the present work was to study the effect of cooked black beans with and without high fat and ...

An everything-but-the-kitchen-sink mapping study of GLP1- receptor agonists compared to other diabetes medications, where 175 health outcomes were assessed between the two groups, was published this year and it highlighted a number of slight risk increases with GLP-1 receptor agonists